Q1 2025 Earnings Estimate for Celsius Holdings, Inc. (NASDAQ:CELH) Issued By Wedbush

Celsius Holdings, Inc. (NASDAQ:CELH) – Equities researchers at Wedbush issued their Q1 2025 earnings per share estimates for Celsius in a note issued to investors on Thursday, September 14th. Wedbush analyst G. Pascarelli expects that the company will earn $0.88 per share for the quarter. Wedbush has a “Outperform” rating and a $180.00 price objective on the stock. The consensus estimate for Celsius’ current full-year earnings is $1.80 per share. Wedbush also issued estimates for Celsius’ Q2 2025 earnings at $1.04 EPS.

Celsius (NASDAQ:CELH) last announced its quarterly earnings results on Tuesday, August 8th. The company reported $0.52 EPS for the quarter, beating analysts’ consensus estimates of $0.26 by $0.26. Celsius had a positive return on equity of 66.52% and a negative net margin of 11.60%. The company had revenue of $325.88 million during the quarter, compared to analysts’ expectations of $277.19 million. During the same period in the prior year, the company earned $0.12 EPS. Celsius’s revenue was up 111.6% compared to the same quarter last year.

CELH has been the topic of a number of other research reports. Piper Sandler increased their price objective on Celsius from $185.00 to $215.00 and gave the stock an “overweight” rating in a report on Tuesday, August 29th. Stifel Nicolaus lifted their price objective on Celsius from $165.00 to $191.00 and gave the stock a “buy” rating in a report on Wednesday, August 9th. TD Cowen started coverage on Celsius in a research report on Friday. They set an “outperform” rating and a $250.00 target price for the company. UBS Group upped their target price on shares of Celsius from $130.00 to $160.00 in a research report on Friday, June 2nd. Finally, Maxim Group downgraded Celsius from a “buy” rating to a “hold” rating in a report on Wednesday, July 19th. One analyst has rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $180.73.

Celsius Stock Performance

Shares of CELH opened at $197.53 on Monday. The business’s 50 day moving average price is $169.26 and its two-hundred day moving average price is $133.06. Celsius has a 52-week low of $78.25 and a 52-week high of $206.85. The firm has a market cap of $15.19 billion, a PE ratio of -103.42 and a beta of 1.78.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Envestnet Asset Management Inc. raised its position in shares of Celsius by 20.9% during the first quarter. Envestnet Asset Management Inc. now owns 5,908 shares of the company’s stock worth $326,000 after purchasing an additional 1,023 shares during the period. JPMorgan Chase & Co. boosted its position in Celsius by 8.5% during the first quarter. JPMorgan Chase & Co. now owns 54,953 shares of the company’s stock worth $3,033,000 after purchasing an additional 4,285 shares during the period. Raymond James Financial Services Advisors Inc. raised its position in shares of Celsius by 4.3% in the first quarter. Raymond James Financial Services Advisors Inc. now owns 9,583 shares of the company’s stock valued at $529,000 after purchasing an additional 398 shares during the period. Bank of New York Mellon Corp boosted its stake in Celsius by 1.9% in the 1st quarter. Bank of New York Mellon Corp now owns 394,530 shares of the company’s stock valued at $21,771,000 after purchasing an additional 7,411 shares during the period. Finally, MetLife Investment Management LLC grew its holdings in Celsius by 53.1% in the 1st quarter. MetLife Investment Management LLC now owns 28,662 shares of the company’s stock valued at $1,582,000 after buying an additional 9,946 shares in the last quarter. 60.32% of the stock is owned by institutional investors.

Insider Buying and Selling

In related news, VP Tony Guilfoyle sold 4,477 shares of the firm’s stock in a transaction that occurred on Monday, August 21st. The shares were sold at an average price of $176.00, for a total transaction of $787,952.00. Following the transaction, the vice president now owns 83,187 shares of the company’s stock, valued at $14,640,912. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. In related news, Director Nicholas Castaldo sold 55,000 shares of the business’s stock in a transaction dated Wednesday, August 23rd. The stock was sold at an average price of $181.58, for a total transaction of $9,986,900.00. Following the transaction, the director now directly owns 110,491 shares in the company, valued at $20,062,955.78. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, VP Tony Guilfoyle sold 4,477 shares of Celsius stock in a transaction dated Monday, August 21st. The shares were sold at an average price of $176.00, for a total transaction of $787,952.00. Following the sale, the vice president now owns 83,187 shares in the company, valued at $14,640,912. The disclosure for this sale can be found here. In the last 90 days, insiders sold 522,632 shares of company stock valued at $91,962,087. Company insiders own 2.70% of the company’s stock.

Celsius Company Profile

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional drinks and liquid supplements in the United States and internationally. The company offers various carbonated and non-carbonated functional energy drinks under the CELSIUS Originals name; dietary supplement in carbonated flavors, including apple jack'd, orangesicle, inferno punch, cherry lime, blueberry pomegranate, strawberry dragon fruit, tangerine grapefruit, and jackfruit under the CELSIUS HEAT name; and branched-chain amino acids functional energy drink that fuels muscle recovery under the CELSIUS BCCA+ENERGY name.